Dual regulation of hepatitis C viral RNA by cellular RNAi requires partitioning of Ago2 to lipid droplets and P-bodies

RNA

Volumn 17, Issue 10, 2011, Pages 1831-1845

  Berezhna, Svitlana Yu ^a   Supekova, Lubica ^a   Sever, Mary J ^a,b   Schultz, Peter G ^a   Deniz, Ashok A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Program on US Russia Relations at Columbia s Harriman Institute   (United States)

Author keywords

Argonaute 2; Dicer; Hepatitis C; miRNA 122; P bodies; RNAi

Indexed keywords

ARGONAUTE 2 PROTEIN; FAT DROPLET; MICRORNA; MICRORNA 122; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; RNA ANALYSIS; RNA INTERFERENCE; RNA REPLICATION; RNA RNA HYBRIDIZATION; RNA SYNTHESIS; VIRUS CORE; VIRUS REPLICATION;

CELL LINE; EUKARYOTIC INITIATION FACTOR-2; HEPACIVIRUS; HUMANS; LIPID METABOLISM; MICRORNAS; RIBONUCLEASE III; RNA INTERFERENCE; RNA, VIRAL;

HEPATITIS C VIRUS;

EID: 80053191351     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.2523911     Document Type: Article

References (67)

1. Aizer A, Brody Y, Ler LW, Sonenberg N, Singer RH, Shav-Tal Y. 2008. The dynamics of mammalian P body transport, assembly, and disassembly in vivo. Mol Biol Cell 19: 4154-4166.
2. Aleman LM, Doench J, Sharp PA. 2007. Comparison of siRNA-induced off-target RNA and protein effects. RNA 13: 385-395.
3. Azuma-Mukai A, Oguri H, Mituyama T, Qian ZR, Asai K, Siomi H, Siomi MC. 2008. Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc Natl Acad Sci 105: 7964-7969.
4. Beckham CJ, Parker R. 2008. P bodies, stress granules, and viral life cycles. Cell Host Microbe 3: 206-212.
5. Berezhna SY, Supekova L, Supek F, Schultz PG, Deniz AA. 2006. siRNA in human cells selectively localizes to target RNA sites. Proc Natl Acad Sci 103: 7682-7687.
6. Bhattacharyya SN, Habermacher R, Martine U, Closs EI, Filipowicz W. 2006. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125: 1111-1124.
7. Bolte S, Cordelieres FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224: 213-232.
8. Boulant S, Targett-Adams P, McLauchlan J. 2007. Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J Gen Virol 88: 2204-2213.
9. Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, et al. 2004. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biology 1: 106-113.
10. Chendrimada TP, Gregory RI, Kumaraswamy E, Norman J, Cooch N, Nishikura K, Shiekhattar R. 2005. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436: 740-744.
11. Chisari FV. 2005. Unscrambling hepatitis C virus-host interactions. Nature 436: 930-932.
12. Chu CY, Rana TM. 2006. Translation repression in human cells by microRNA-induced gene silencing requires RCK/p54. PLoS Biol 4: e210. doi: 10.1371/journal.pbio.0040210.
13. Cullen BR. 2006. Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat Immunol 7: 563-567.
14. Cullen BR. 2010. Five questions about viruses and microRNAs. PLoS Pathog 6: e1000787. doi: 10.1371/journal.ppat.1000787.
15. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S, Lindholm M, Hedtjarn M, Hansen HF, Berger U, et al. 2008. LNA-mediated microRNA silencing in nonhuman primates. Nature 452: 896-899.
16. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M, Watts L, Booten SL, Graham M, McKay R, et al. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3: 87-98.
17. Eulalio A, Behm-Ansmant I, Izaurralde E. 2007. P bodies: at the crossroads of post-transcriptional pathways. Nat Rev Mol Cell Biol 8: 9-22.
18. Eulalio A, Tritschler F, Izaurralde E. 2009. The GW182 protein family in animal cells: New insights into domains required for miRNA-mediated gene silencing. RNA 15: 1433-1442.
19. French AP, Mills S, Swarup R, Bennett MJ, Pridmore TP. 2008. Colocalization of fluorescent markers in confocal microscope images of plant cells. Nat Protoc 3: 619-628.
20. Gosert R, Egger D, Lohmann V, Bartenschlager R, Blum HE, Bienz K, Moradpour D. 2003. Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J Virol 77: 5487-5492.
21. Henke JI, Goergen D, Zheng J, Song Y, Schuttler CG, Fehr C, Junemann C, Niepmann M. 2008. microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 27: 3300-3310.
22. Herker E, Harris C, Hernandez C, Carpentier A, Kaehlcke K, Rosenberg AR, Farese RV, Ott M. 2010. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med 16: 1295-1298.
23. Ikeda K, Satoh M, Pauley KM, Fritzler MJ, Reeves WH, Chan EK. 2006. Detection of the argonaute protein Ago2 and microRNAs in the RNA-induced silencing complex (RISC) using a monoclonal antibody. J Immunol Methods 317: 38-44.
24. Jakymiw A, Lian S, Eystathioy T, Li S, Satoh M, Hamel JC, Fritzler MJ, Chan EK. 2005. Disruption of GW bodies impairs mammalian RNA interference. Nat Cell Biol 7: 1267-1274.
25. Jangra RK, Yi M, Lemon SM. 2010a. DDX6 (Rck/p54) Is required for efficient hepatitis C virus replication but not for internal ribosome entry site-directed translation. J Virol 84: 6810-6824.
26. Jangra RK, Yi M, Lemon SM. 2010b. Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J Virol 84: 6615-6625.
27. Ji J, Glaser A, Wernli M, Berke JM, Moradpour D, Erb P. 2008. Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus. J Gen Virol 89: 2761-2766.
28. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309: 1577-1581.
29. Joshua-Tor L. 2006. The Argonautes. Cold Spring Harb Symp Quant Biol 71: 67-72.
30. Kapadia SB, Brideau-Andersen A, Chisari FV. 2003. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci 100: 2014-2018.
31. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. 2005. Silencing of microRNAs in vivo with "antagomirs." Nature 438: 685-689.
32. Kulkarni M, Ozgur S, Stoecklin G. 2010. On track with P-bodies. Biochem Soc Trans 38: 242-251.
33. Leung AK, Calabrese JM, Sharp PA. 2006. Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules. Proc Natl Acad Sci 103: 18125-18130.
34. Lian S, Fritzler MJ, Katz J, Hamazaki T, Terada N, Satoh M, Chan EK. 2007. Small interfering RNA-mediated silencing induces target-dependent assembly of GW/P bodies. Mol Biol Cell 18: 3375-3387.
35. Lin J, Cullen BR. 2007. Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J Virol 81: 12218-12226.
36. Liu J, Rivas FV, Wohlschlegel J, Yates JR III, Parker R, Hannon GJ. 2005a. A role for the P-body component GW182 in microRNA function. Nat Cell Biol 7: 1261-1266.
37. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R. 2005b. Micro-RNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol 7: 719-723.
38. Lohmann V, Korner F, Koch J, Herian U, Theilmann L, Bartenschlager R. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285: 110-113.
39. MacRae IJ, Ma E, Zhou M, Robinson CV, Doudna JA. 2008. In vitro reconstitution of the human RISC-loading complex. Proc Natl Acad Sci 105: 512-517.
40. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T. 2004. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 15: 185-197.
41. Meister G, Landthaler M, Peters L, Chen PY, Urlaub H, Luhrmann R, Tuschl T. 2005. Identification of novel argonaute-associated proteins. Curr Biol 15: 2149-2155.
42. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, Bartenschlager R, Wakita T, Hijikata M, Shimotohno K. 2007. The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9: 1089-1097.
43. Moradpour D, Englert C, Wakita T, Wands JR. 1996. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 222: 51-63.
44. Moradpour D, Brass V, Bieck E, Friebe P, Gosert R, Blum HE, Bartenschlager R, Penin F, Lohmann V. 2004. Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication. J Virol 78: 13278-13284.
45. Moser JJ, Eystathioy T, Chan EKL, Fritzler MJ. 2007. Markers of mRNA stabilization and degradation, and RNAi within astrocytoma GW bodies. J Neurosci Res 85: 3619-3631.
46. Norman KL, Sarnow P. 2010. Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR-122 involves distinct mechanisms. J Virol 84: 666-670.
47. Parameswaran P, Sklan E, Wilkins C, Burgon T, Samuel MA, Lu R, Ansel KM, Heissmeyer V, Einav S, Jackson W, et al. 2010. Six RNA viruses and forty-one hosts: Viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog 6: e1000764. doi: 10.1371/journal.ppat. 1000764.
48. Pfeffer S. 2010. RNA silencing as a natural antiviral defense system in mammals: Where are we now? Mol Ther 18: 871-872.
49. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grässer FA, van Dyk LF, Ho CK, Shuman S, Chien M, et al. 2005. Identification of microRNAs of the herpesvirus family. Nat Methods 2: 269-276.
50. Pietschmann T, Lohmann V, Kaul A, Krieger N, Rinck G, Rutter G, Strand D, Bartenschlager R. 2002. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J Virol 76: 4008-4021.
51. Randall G, Grakoui A, Rice CM. 2003. Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs. Proc Natl Acad Sci 100: 235-240.
52. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, Pfeffer S, Landthaler M, Landgraf P, Kan S, Lindenbach BD, et al. 2007. Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci 104: 12884-12889.
53. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W. 2009. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 15: 31-33.
54. Scheller N, Mina LB, Galao RP, Chari A, Gimenez-Barcons M, Noueiry A, Fischer U, Meyerhans A, Diez J. 2009. Translation and replication of hepatitis C virus genomic RNA depends on ancient cellular proteins that control mRNA fates. Proc Natl Acad Sci 106: 13517-13522.
55. Schonborn J, Oberstrass J, Breyel E, Tittgen J, Schumacher J, Lukacs N. 1991. Monoclonal antibodies to double-stranded RNA as probes of RNA structure in crude nucleic acid extracts. Nucleic Acids Res 19: 2993-3000.
56. Shavinskaya A, Boulant S, Penin F, McLauchlan J, Bartenschlager R. 2007. The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J Biol Chem 282: 37158-37169.
57. Simons K, Vaz WL. 2004. Model systems, lipid rafts, and cell membranes. Annu Rev Biophys Biomol Struct 33: 269-295.
58. Strzelecka M, Trowitzsch S, Weber G, Luhrmann R, Oates AC, Neugebauer KM. 2010. Coilin-dependent snRNP assembly is essential for zebrafish embryogenesis. Nat Struct Mol Biol 17: 403-409.
59. Supekova L, Supek F, Lee J, Chen S, Gray N, Pezacki JP, Schlapbach A, Schultz PG. 2008. Identification of human kinases involved in hepatitis C virus replication by small interference RNA library screening. J Biol Chem 283: 29-36.
60. Targett-Adams P, Boulant S, McLauchlan J. 2008. Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication. J Virol 82: 2182-2195.
61. Tellinghuisen TL, Evans MJ, von Hahn T, You S, Rice CM. 2007. Studying hepatitis C virus: Making the best of a bad virus. J Virol 81: 8853-8867.
62. Umbach JL, Cullen BR. 2009. The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev 23: 1151-1164.
63. Vasudevan S, Steitz JA. 2007. AU-rich-element-mediated up-regulation of translation by FXR1 and Argonaute 2. Cell 128: 1105-1118.
64. Vasudevan S, Tong Y, Steitz JA. 2007. Switching from repression to activation: MicroRNAs can up-regulate translation. Science 318: 1931-1934.
65. Wang Y, Kato N, Jazag A, Dharel N, Otsuka M, Taniguchi H, Kawabe T, Omata M. 2006. Hepatitis C virus core protein is a potent inhibitor of RNA silencing-based antiviral response. Gastroenterology 130: 883-892.
66. Weinmann L, Höck J, Ivacevic T, Ohrt T, Mütze J, Schwille P, Kremmer E, Benes V, Urlaub H, Meister G. 2009. Importin 8 is a gene silencing factor that targets Argonaute proteins to distinct mRNAs. Cell 136: 496-507.
67. Yoon JH, Parker R. 2010. Coil-in-to snRNP assembly and Cajal bodies. Nat Struct Mol Biol 17: 391-393.